Miqnaf Approved by DCGI, launched May 27, 2025 Used in community-acquired pneumonia and respiratory tract infections Addresses macrolide resistance (azithromycin resistance is widespread) and is quinolone-sparing Dedicated business unit created for specialist-focused commercialization Saudi Arabia: Received Breakthrough Medicinal Product (BMP) status - facilitating accelerated approval 3
ClinSci (Lond) 1993;85(3 ): 27780
Micallef et al., 2020a
The NativePath website offers a streamlined ordering process with secure checkout and detailed product information to support your muscle support supplement buying guide research
[DOI] [PubMed] [Google Scholar] 104.Mller T.D., Finan B., Bloom S.R., DAlessio D., Drucker D.J., Flatt P.R., Fritsche A., Gribble F., Grill H.J., Habener J.F., et al